Trial Profile
Verteporfin Photodynamic Therapy in subfoveal choroidal neovascularisation: The UK cohort study
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 13 Mar 2007
Price :
$35
*
At a glance
- Drugs Verteporfin (Primary)
- Indications Choroidal neovascularisation
- Focus Therapeutic Use
- 13 Mar 2007 New trial record.